The Amgen investment will bring Puerto Rico's biomanufacturing facility commitment to nearly $1 billion, reinforcing US ...

Switzerland's DINAMIQS receives Swissmedic approval for GMP viral vector production, becoming the country's first fully ...

Blood centers are scaling cell and gene therapies by leveraging decades of expertise in apheresis, logistics, and quality ...

High-throughput virology, design of experiments, and small-molecule production enhancers optimize yield and increase ...

GeoVax CEO David Dodd highlights the need for U.S. manufacturing to reduce reliance on foreign biotech and strengthen ...

Andelyn Biosciences and ENCell collaborate to streamline gene therapy development, leveraging US–APAC networks for faster ...

Novartis announces a new API facility in Morrisville, NC, as part of its $23bn US manufacturing expansion, boosting biopharma ...

Biotechnology giant Thermo Fisher Scientific announced the opening of a US Bioprocess Design Center (BDC) on its campus in ...

Process intensification has reduced the cost of mAb manufacturing, but tweaks across bioproduction will be needed to reduce ...

EU Biotech Act I simplifies trials, boosts biomanufacturing, and aims for €10B investment to strengthen Europe's health ...

AI governance is not merely a regulatory requirement, but also the strategic infrastructure that enables sustainable ...

Recently, artificial intelligence (AI ) company OpenProtein.AI announced its partnership with large pharmaceutical ...